+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Musculoskeletal Disorders Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 5028636
  • Report
  • May 2020
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories Inc
  • Daiichi Sankyo Company
  • F. Hoffmann-La Roche Ltd
  • GlaxosmithKline Plc
  • Pfizer Inc
  • MORE
Musculoskeletal Disorders Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal disorders drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Musculoskeletal Disorders Drugs market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider musculoskeletal disorders drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The musculoskeletal disorders drugs market section of the report gives context. It compares the musculoskeletal disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, musculoskeletal disorders drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: F. Hoffmann-La Roche Ltd; GlaxosmithKline Plc; Pfizer Inc; Abbott Laboratories Inc; Daiichi Sankyo Company

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc
  • Daiichi Sankyo Company
  • F. Hoffmann-La Roche Ltd
  • GlaxosmithKline Plc
  • Pfizer Inc
  • MORE
1. Executive Summary

2. Report Structure

3. Musculoskeletal Disorders Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Musculoskeletal Disorders Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Musculoskeletal Disorders Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Musculoskeletal Disorders Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Musculoskeletal Disorders Drugs Market Trends And Strategies

8. Musculoskeletal Disorders Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Musculoskeletal Disorders Drugs Market Regional Analysis
9.1. Global Musculoskeletal Disorders Drugs Market, 2019, By Region, Value ($ Billion)
9.2. Global Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Musculoskeletal Disorders Drugs Market Segmentation
10.1. Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Drugs For Rheumatoid Arthritis
  • Muscle Relaxants
  • Others - Musculoskeletal Disorders Drugs
10.2. Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
10.3. Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
10.4. Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
10.5. Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
11. Musculoskeletal Disorders Drugs Market Metrics
11.1. Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global
11.2. Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Musculoskeletal Disorders Drugs Market
12.1. Asia-Pacific Musculoskeletal Disorders Drugs Market Overview
12.2. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
12.3. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
12.4. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Musculoskeletal Disorders Drugs Market Metrics
12.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries
12.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Asia-Pacific Countries
12.6. Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7. Asia-Pacific Musculoskeletal Disorders Drugs Market: Country Analysis
12.7.1. China Musculoskeletal Disorders Drugs Market
12.7.1.1. China Musculoskeletal Disorders Drugs Market Overview
12.7.1.2. China Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.1.3. China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2. Australia Musculoskeletal Disorders Drugs Market
12.7.2.1. Australia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2.2. Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.3. Hong Kong Musculoskeletal Disorders Drugs Market
12.7.3.1. Hong Kong Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4. India Musculoskeletal Disorders Drugs Market
12.7.4.1. India Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4.2. India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5. Indonesia Musculoskeletal Disorders Drugs Market
12.7.5.1. Indonesia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5.2. Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6. Japan Musculoskeletal Disorders Drugs Market
12.7.6.1. Japan Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6.2. Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.7. Malaysia Musculoskeletal Disorders Drugs Market
12.7.7.1. Malaysia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.8. New Zealand Musculoskeletal Disorders Drugs Market
12.7.8.1. New Zealand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.9. Philippines Musculoskeletal Disorders Drugs Market
12.7.9.1. Philippines Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.10. Singapore Musculoskeletal Disorders Drugs Market
12.7.10.1. Singapore Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11. South Korea Musculoskeletal Disorders Drugs Market
12.7.11.1. South Korea Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11.2. South Korea Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.12. Thailand Musculoskeletal Disorders Drugs Market
12.7.12.1. Thailand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.13. Vietnam Musculoskeletal Disorders Drugs Market
12.7.13.1. Vietnam Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Musculoskeletal Disorders Drugs Market
13.1. Western Europe Musculoskeletal Disorders Drugs Market Overview
13.2. Western Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
13.3. Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Western Europe, Musculoskeletal Disorders Drugs Market Metrics
13.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Western Europe Countries
13.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Western Europe Countries
13.6. Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Western Europe Musculoskeletal Disorders Drugs Market: Country Analysis
13.7.1. Austria Musculoskeletal Disorders Drugs Market
13.7.1.1. Austria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Belgium Musculoskeletal Disorders Drugs Market
13.7.2.1. Belgium Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Denmark Musculoskeletal Disorders Drugs Market
13.7.3.1. Denmark Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. Finland Musculoskeletal Disorders Drugs Market
13.7.4.1. Finland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. France Musculoskeletal Disorders Drugs Market
13.7.5.1. France Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Germany Musculoskeletal Disorders Drugs Market
13.7.6.1. Germany Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Ireland Musculoskeletal Disorders Drugs Market
13.7.7.1. Ireland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. Italy Musculoskeletal Disorders Drugs Market
13.7.8.1. Italy Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Netherlands Musculoskeletal Disorders Drugs Market
13.7.9.1. Netherlands Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Norway Musculoskeletal Disorders Drugs Market
13.7.10.1. Norway Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. Portugal Musculoskeletal Disorders Drugs Market
13.7.11.1. Portugal Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Spain Musculoskeletal Disorders Drugs Market
13.7.12.1. Spain Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Sweden Musculoskeletal Disorders Drugs Market
13.7.13.1. Sweden Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.14. Switzerland Musculoskeletal Disorders Drugs Market
13.7.14.1. Switzerland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15. UK Musculoskeletal Disorders Drugs Market
13.7.15.1. UK Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15.2. UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Musculoskeletal Disorders Drugs Market
14.1. Eastern Europe Musculoskeletal Disorders Drugs Market Overview
14.2. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
14.3. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Musculoskeletal Disorders Drugs Market Metrics
14.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries
14.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Eastern Europe Countries
14.6. Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Eastern Europe Musculoskeletal Disorders Drugs Market: Country Analysis
14.7.1. Czech Republic Musculoskeletal Disorders Drugs Market,
14.7.1.1. Czech Republic Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Poland Musculoskeletal Disorders Drugs Market
14.7.2.1. Poland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Romania Musculoskeletal Disorders Drugs Market
14.7.3.1. Romania Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Russia Musculoskeletal Disorders Drugs Market
14.7.4.1. Russia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4.2. Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Musculoskeletal Disorders Drugs Market
15.1. North America Musculoskeletal Disorders Drugs Market Overview
15.2. North America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
15.3. North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. North America, Musculoskeletal Disorders Drugs Market Metrics
15.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, North America Countries
15.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, North America Countries
15.6. North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. North America Musculoskeletal Disorders Drugs Market: Country Analysis
15.7.1. Canada Musculoskeletal Disorders Drugs Market
15.7.1.1. Canada Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Mexico Musculoskeletal Disorders Drugs Market
15.7.2.1. Mexico Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. USA Musculoskeletal Disorders Drugs Market
15.7.3.1. USA Musculoskeletal Disorders Drugs Market Overview
15.7.3.2. USA Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3.3. USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Musculoskeletal Disorders Drugs Market
16.1. South America Musculoskeletal Disorders Drugs Market Overview
16.2. South America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
16.3. South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. South America, Musculoskeletal Disorders Drugs Market Metrics
16.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, South America Countries
16.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, South America Countries
16.6. South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. South America Musculoskeletal Disorders Drugs Market: Country Analysis
16.7.1. Argentina Musculoskeletal Disorders Drugs Market
16.7.1.1. Argentina Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Brazil Musculoskeletal Disorders Drugs Market
16.7.1.1. Brazil Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2.2. Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. Chile Musculoskeletal Disorders Drugs Market
16.7.3.1. Chile Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.4. Colombia Musculoskeletal Disorders Drugs Market
16.7.4.1. Colombia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.5. Peru Musculoskeletal Disorders Drugs Market
16.7.5.1. Peru Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.6. Venezuela Musculoskeletal Disorders Drugs Market
16.7.6.1. Venezuela Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Musculoskeletal Disorders Drugs Market
17.1. Middle East Musculoskeletal Disorders Drugs Market Overview
17.2. Middle East, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
17.3. Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. Middle East, Musculoskeletal Disorders Drugs Market Metrics
17.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Middle East Countries
17.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Middle East Countries
17.6. Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. Middle East Musculoskeletal Disorders Drugs Market: Country Analysis
17.7.1. Saudi Arabia Musculoskeletal Disorders Drugs Market
17.7.1.1. Saudi Arabia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Israel Musculoskeletal Disorders Drugs Market
17.7.2.1. Israel Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Turkey Musculoskeletal Disorders Drugs Market
17.7.3.1. Turkey Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. UAE Musculoskeletal Disorders Drugs Market
17.7.4.1. UAE Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Musculoskeletal Disorders Drugs Market
18.1. Africa Musculoskeletal Disorders Drugs Market Overview
18.2. Africa, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
18.3. Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Africa, Musculoskeletal Disorders Drugs Market Metrics
18.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Africa Countries
18.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Africa Countries
18.6. Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Africa Musculoskeletal Disorders Drugs Market: Country Analysis
18.7.1. Egypt Musculoskeletal Disorders Drugs Market
18.7.1.1. Egypt Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Nigeria Musculoskeletal Disorders Drugs Market
18.7.2.1. Nigeria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. South Africa Musculoskeletal Disorders Drugs Market
18.7.3.1. South Africa Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Musculoskeletal Disorders Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. F. Hoffmann-La Roche Ltd
19.3.1.1. Company Overview
19.3.1.2. Products And Services
19.3.1.3. Strategy
19.3.1.4. Financial Performance
19.3.2. GlaxosmithKline Plc
19.3.2.1. Company Overview
19.3.2.2. Products And Services
19.3.2.3. Strategy
19.3.2.4. Financial Performance
19.3.3. Pfizer Inc
19.3.3.1. Company Overview
19.3.3.2. Products And Services
19.3.3.3. Strategy
19.3.3.4. Financial Performance
19.3.4. Abbott Laboratories Inc
19.3.4.1. Company Overview
19.3.4.2. Products And Services
19.3.4.3. Strategy
19.3.4.4. Financial Performance
19.3.5. Daiichi Sankyo Company
19.3.5.1. Company Overview
19.3.5.2. Products And Services
19.3.5.3. Strategy
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Musculoskeletal Disorders Drugs Market

21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations
22.1. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Countries
22.2. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Segments
22.3. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Strategies

23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher

24. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc
  • Daiichi Sankyo Company
  • F. Hoffmann-La Roche Ltd
  • GlaxosmithKline Plc
  • Pfizer Inc
  • MORE
North America was the largest region in the global musculoskeletal disorders drugs market, accounting for 53% of the market in 2019. Asia Pacific was the second largest region accounting for 27% of the global musculoskeletal disorders drugs market. Africa was the smallest region in the global musculoskeletal disorders drugs market.

Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-Articular drug delivery systems are also widely being used to administer medicines to treat arthritis. In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.

The musculoskeletal disorders drugs market consists of sales of musculoskeletal disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce musculoskeletal disorders drugs to treat musculoskeletal disorders such as arthritis, osteoporosis, osteomalacia, and other disorders. This industry includes establishments that produce drugs to treat rheumatoid arthritis, muscle relaxants to reduce muscle pain, and other drugs used in treating osteoarthritis, analgesics drugs, immunosuppressives.

The global musculoskeletal disorders drugs market is expected to decline from $85.7 billion in 2019 to $75.5 billion in 2020 at a compound annual growth rate (CAGR) of -12%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The restrictions on non-essential medical services coupled with slowed production of drugs due to extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 4% from 2021 and reach $94.8 billion in 2023.
Note: Product cover images may vary from those shown
4 of 5
  • F. Hoffmann-La Roche Ltd
  • GlaxosmithKline Plc
  • Pfizer Inc
  • Abbott Laboratories Inc
  • Daiichi Sankyo Company
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll